Voyager Therapeutics, Inc.
AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE
Last updated:
Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.
Status:
Application
Type:
Utility
Filling date:
26 Jul 2019
Issue date:
14 Nov 2019